glucose, (beta-d)-isomer has been researched along with Ventricular Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furukawa, S; Hiasa, Y; Matsuura, B; Miki, T; Miura, T; Ohnishi, H; Sato, T; Tanno, M | 1 |
Chen, HL; Chen, JX; Guo, ZY; Jiang, W; Li, P; Li, RL; Wang, X; Wang, XL; Wang, XX; Xiong, LL; Zhu, Y | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Ventricular Dysfunction
Article | Year |
---|---|
Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Follow-Up Studies; Glucosides; Humans; Longitudinal Studies; Middle Aged; Prognosis; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction | 2019 |
Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Cell Size; Cell Survival; Clone Cells; Doxorubicin; Gene Expression Regulation, Enzymologic; Glucosides; Heart Ventricles; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Oxidoreductases; Phenols; Random Allocation; Rats; Ventricular Dysfunction | 2013 |